H. Tölö

A modified caprylic acid method for manufacturing immunoglobulin G from human plasma with high yield and efficient virus clearance

J. Parkkinen, A. Rahola, L. Bonsdorff, 2006, Vox sanguinis.

Leukocyte interferon-alpha in the treatment of chronic hepatitis C in Finland.

M. Färkkilä, M. Lappalainen, R. Julkunen, 2000, Scandinavian journal of gastroenterology.

Biosynthesis and N-glycosylation of human interferon-gamma. Asn25 and Asn97 differ markedly in how efficiently they are glycosylated and in their oligosaccharide composition.

P. Roepstorff, I. Julkunen, T. Sareneva, 1996, European journal of biochemistry.

Long-term persistence of selective IgA deficiency in healthy adults

S. Koskinen, H. Toeloe, J. Koistinen, 1994, Journal of Clinical Immunology.

Conjugation of interferon alpha to a humanized monoclonal antibody (HuBrE-3vl) enhances the selective localization and antitumor effects of interferon in breast cancer xenografts

K. Cantell, R. Ceriani, H. Toeloe, 1998, Breast Cancer Research and Treatment.

Determination of anti-IgA antibodies with a flow cytometer-based microbead immunoassay (MIA).

T. Krusius, M. Syrjälä, H. Toeloe, 1991, Journal of immunological methods.

An enzyme immunoassay for the determination of anti-IgA antibodies using polyclonal human IgA.

S. Koskinen, H. Toeloe, M. Hirvonen, 1995, Journal of immunological methods.

Development of a Highly Purified Multicomponent Leukocyte IFN-α Product

J. Parkkinen, G. Alm, H. Toeloe, 2001 .

Development of a pharmaceutical apotransferrin product for iron binding therapy.

J. Parkkinen, H. Toeloe, L. von Bonsdorff, 2001, Biologicals : journal of the International Association of Biological Standardization.

Viral safety of Nanogam®, a new 15 nm‐filtered liquid immunoglobulin product

J. Parkkinen, F. Terpstra, L. Bonsdorff, 2006, Vox sanguinis.

Quantitation of IgA in Human Whole Saliva

S. Alaluusua, H. Toeloe, E. Grönblad, 1981 .